Antinuclear antibody positive in patients with primary immune thrombocytopenia: incidence and risk prediction of developing autoimmune diseases
These findings suggest that ANA-positive primary ITP is a clinical entity distinct from other primary ITP and is associated with an increased risk of developing AIDs, especially SJD.
Authors
- Sha Li (ORCID: https://orcid.org/0000-0003-0628-8853)
- Shuya Wang (ORCID: https://orcid.org/0000-0002-3092-6723)
- Hui Liang (ORCID: https://orcid.org/0000-0003-1460-8335)
- Changyan Sun (ORCID: https://orcid.org/0000-0002-3251-4992)
- Zhen Li (ORCID: https://orcid.org/0000-0003-2771-3425)
- Shumin Dong
- Songyuan Tie
- Manyu Long
Institutions
- Kunming University of Science and Technology (CN)
- First People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1080/16078454.2025.2551454
- Citations
- 2
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54